Initial uterine alterations caused by developmental exposure to tamoxifen

Reproductive Toxicology

Volumn 11, Issue 6, 1997, Pages 815-822

  Poulet, Frederique M ^a   Roessler, Michele L ^a   Vancutsem, Paul M ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Bromodeoxyuridine immunohistochemistry; Developmental toxicant; Histogenesis; Morphometry; Neonatal model; Rat uterus; Tamoxifen

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; DIETHYLSTILBESTROL; TAMOXIFEN;

ANIMAL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL DIVISION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FEMALE GENITAL TRACT MALFORMATION; GROWTH, DEVELOPMENT AND AGING; HISTOGENESIS; IATROGENIC DISEASE; IMMUNOHISTOCHEMISTRY; NONHUMAN; ORGAN WEIGHT; PATHOLOGY; RAT; RAT STRAIN; REPRODUCTIVE TOXICITY; SUBCUTANEOUS DRUG ADMINISTRATION; TERATOGENICITY; UTERUS; UTERUS DISEASE; UTERUS MALFORMATION;

EID: 0031282705     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)00065-8     Document Type: Article

References (45)

1. 1. Jordan VC. Studies on the estrogen receptor in breast cancer - 20 years as a target for the treatment and prevention of cancer. Breast Cancer Res Treat. 1995;36:267-85.
2. 2. Clark S. Prophylactic tamoxifen. Lancet. 1993;342:168.
3. 3. Cullins SL, Pridjian G, Sutherland CM. Goldenhar's syndrome associated with tamoxifen given to the mother during gestation. JAMA 1994;271:1905-6.
4. 4. Iguchi T, Ohta Y. Cellular effects of early exposure to tamoxifen. In: Kellen JA, ed. Tamoxifen, beyond the antiestrogen. Boston: Birkhauser; 1996:179-99.
5. 5. Vancutsem P, Williams GM. Tamoxifen and teratogenicity in animals. Lancet. 1993;342:873-4.
6. 6. Furr BJA, Jordan VC. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther. 1984;25:127-205.
7. 7. McCormack S, Clark JH. Clomid administration to pregnant rats causes abnormalities of the reproductive tract in offspring and mothers. Science (Washington DC). 1979;204:629-31.
8. 8. Clark JH, McCormack S. Clomid or nafoxidine administered to neonatal rats causes reproductive tract abnormalities. Science (Washington DC). 1977;197:164-5.
9. 9. Chamness GC, Bannayan GA, Landry LA Jr, Sheridan PJ, McGuire WL. Abnormal reproductive development in rats after neonatally administered antiestrogen (tamoxifen). Biol Reprod. 1979;21:1087-90.
10. 10. Holinka CF, Bressler RS, Zehr DR, Gurpide E. Comparison of effects of estetrol and tamoxifen with those of estriol and estradiol on the immature rat uterus. Biol Reprod. 1980;22:913-26.
11. 11. Iguchi T, Todoroki R, Yamaguchi S, Takasugi N. Changes in the uterus and vagina of mice treated neonatally with antiestrogens. Acta Anat (Basel). 1989;136:146-54.
12. 12. Iguchi T, Hirokawa M, Takasugi N. Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen. Toxicology. 1986;42:1-11.
13. 13. Forsberg J-G. Treatment with different antiestrogens in the neonatal period and effects in the cervicovaginal epithelium and ovaries of adult mice: a comparison to estrogen-induced changes. Biol Reprod. 1985;32:427-41.
14. 14. Newbold R, Bullock B, Jefferson W, Padilla-Burgos E. Effects of developmental exposure of mice to tamoxifen [abstract 753]. Proc Am Assoc Cancer Res. 1996;37:109.
15. 15. Pasqualini JR, Giambiagi N, Sumida C, Nguyen B-L, Gelly C, Mayrand C, Lecerf F. Biological responses of tamoxifen in the fetal and newborn vagina and uterus of the guinea-pig and in the R-27 mammary cancer cell line. J Steroid Biochem. 1986;24:99-108.
16. 16. Mittendorf R. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES). in utero. Teratology. 1995;51:435-45.
17. 17. Cunha GR, Taguchi O, Namikawa R, Nishizuka Y, Robboy SJ. Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract. Hum Pathol. 1987;18:1132-43.
18. 18. King CM. Tamoxifen and the induction of cancer. Carcinogenesis (Lond.). 1995;16:1449-54.
19. 19. Seoud MA-F, Johnson J, Weed JC Jr. Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol. 1993;82:165-9.
20. 20. Tamoxifen labeled carcinogen. Science (Washington DC). 1996; 271:1367.
21. 21. Walker BE. Animal models of prenatal exposure to diethylstilboestrol. In: Nalpalkov NP, Rice JM, Tomatis L, Yamasaki H, eds. Perinatal and multigeneration carcinogenesis. Lyon: IARC; 1989: 349-64.
22. 22. Forsberg J-G. Developmental mechanism of estrogen-induced irreversible changes in the mouse cervicovaginal epithelium. Natl Cancer Inst Monogr. 1979;51:41-56.
23. 23. Takasugi N. Development of permanently proliferated and cornified vaginal epithelium in mice treated neonatally with steroid hormones and the implication in tumorigenesis. Natl Cancer Inst Monogr. 1979;51:57-66.
24. 24. Robboy SJ, Scully RE, Welch WR, Herbst AL. Intrauterine diethylstilbestrol exposure and its consequences. Pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions. Arch Pathol Lab Med. 1977;101:1-5.
25. 25. Skidmore J(R), Walpole AL, Woodburn J. Effect of some triphenylethylenes on oestradiol binding in vitro to macromolecules from uterus and anterior pituitary. J Endocrinol. 1972;52:289-98.
26. 26. Korach KS, Metzler M, McLachlan JA. Diethylstilbestrol metabolites and analogs. J Biol Chem. 1979;25:8963-8.
27. 27. Debus E, Weber K, Osborn M. Monoclonal antibodies to desmin, the muscle-specific intermediate filament protein. EMBO J. 1983; 2:2305-12.
28. 28. Jordan VC. The development of tamoxifen for breast cancer therapy. In: Jordan VC, ed. Long-term tamoxifen treatment for breast cancer. Madison: The University of Wisconsin Press; 1994:3-26.
29. 29. Lien EA, Solheim E, Ueland PM. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Res. 1991;51:4837-44.
30. 30. Singh M, Singhi S. Possible relationship between clomiphene and neural tube defects. J Pediatr. 1978;93:152.
31. 31. Newbold RR, Bullock BC, McLachlan JA. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res. 1990;50:7677-81.
32. 32. Vorherr H, Messer RH, Vorherr UF, Jordan SW, Kornfeld M. Teratogenesis and carcinogenesis in rat offspring after transplacental and transmammary exposure to diethylstilbestrol. Biochem Pharmacol. 1979;28:1865-77.
33. 33. Walker BE. Uterine tumors in old female mice exposed prenatally to diethylstilbestrol. J Natl Cancer Inst. 1983;70:477-84.
34. 34. Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos. 1990;19:36-43.
35. 35. Forsberg J-G. An estradiol mitotic rate inhibiting effect in the Müllerian epithelium in neonatal mice. J Exp Zool. 1970;175:369-74.
36. 36. Bigsby RM, Cunha GR. Estrogen stimulation of deoxyribonucleic acid synthesis in uterine epithelial cells which lack estrogen receptors. Endocrinology. 1986;119:390-6.
37. 37. Suzuki A, Enari M, Iguchi T. Effect of neonatal exposure to DES in Fas and Bcl-2 expression in the adult mouse vagina and approach to the DES syndrome. Reprod Toxicol. 1996;10:465-70.
38. 38. Branham WS, Sheehan DM, Zehr DR, Medlock KL, Nelson CJ, Ridlon E. Inhibition of rat uterine gland genesis by tamoxifen. Endocrinology. 1985;117:2238-48.
39. 39. Branham WS, Sheehan DM, Zehr DR, Ridlon E, Nelson CJ. The postnatal ontogeny of rat uterine glands and age-related effects of 17β-estradiol. Endocrinology. 1985;117:2229-37.
40. 40. Ostrander PL, Mills KT, Bern HA. Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure. J Natl Cancer Inst. 1985;74:121-35.
41. 41. Campbell PS, Satterfield PM. Effect of neonatal exposure to the antiestrogens nafoxidine and CI-628 upon the development of the uterus in the prepubertal rat. J Reprod Fert. 1988;83:225-31.
42. 42. Ohta Y, Iguchi T, Takasugi N. Deciduoma formation in rats treated neonatally with the anti-estrogens, tamoxifen and MER-25. Reprod Toxicol. 1989;3:207-12.
43. 43. Takamatsu Y, Iguchi T, Takasugi N. Effects of postpubertal treatment with diethylstilbestrol and tamoxifen on protein expression in the vagina and uterus of neonatally diethylstilbestrol-exposed mice. In Vivo. 1992;6:271-8.
44. 44. Greco TL, Duello TM, Gorski J. Estrogen receptors, estradiol, and diethylstilbestrol in early development: the mouse as a model for the study of estrogen receptors and estrogen sensitivity in embryonic development of male and female reproductive tracts. Endocrin Rev. 1993;14:59-71.
45. 45. Sato T, Ohta Y, Okamura H, Hayashi S, Iguchi T. Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol. Anat Rec. 1996;244:374-85.